Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Powered Toothbrush Versus Manual Toothbrush on Plaque and Gingivitis After a Six-Week Period of Home Use

7. juli 2026 opdateret af: Philips Clinical & Medical Affairs Global

A Randomized, Parallel Design Study to Compare the Effects of A New Philips Sonicare Brush Head Versus Manual Toothbrush on Plaque and Gingivitis After a Six-Week Period of Home Use

The goal of this clinical trial is to learn if powered toothbrushing is more effective than manual toothbrushing in removing dental plaque. It will also learn about the safety of power toothbrushing. The main questions the study aims to answer are:

Does power toothbrushing remove more dental plaque than manual toothbrushing? Does power toothbrushing reduce symptoms of gingivitis better than manual toothbrushing?

Participants will:

Brush their teeth twice a day with either a manual or power toothbrush Visit the clinic twice during the study, after two and six weeks after the study starts.

Keep a diary of when they brushed their teeth

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

104

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Indiana
      • Fort Wayne, Indiana, Forenede Stater, 46825
        • Salus Research Inc

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Be willing and physically able to carry out all study procedures and be available at all times required for participation
  • Be able to fully understand and comply with the written and verbal instructions provided
  • Provide written informed consent
  • Willing to attend all study visits
  • Agree to return study materials at the required visit(s)
  • Between the ages of 18-65 years
  • A non-smoker
  • Minimum of 20 'scorable' teeth (excluding 3rd molars)
  • Average plaque score of >1.8 per Modified Plaque Index scoring with 3-6 hours of plaque accumulation
  • Gingival bleeding score of >1 on a minimum of 50 gingival sites per Gingival Bleeding Index
  • Regular manual toothbrush user

Exclusion Criteria:

  • Pregnant or nursing per subject report
  • A medical or dental condition that would be unduly affected by participation in this study, per Investigator discretion
  • A medical condition requiring antibiotic pre-medication prior to dental appointments
  • Diagnosis of xerostomia
  • Oral or extra oral piercing that interferes with the ability to perform study procedures and/or clinical assessments in the mouth
  • Currently undergoing or requiring dental/periodontal treatment, or having had periodontal treatment in the six months preceding the study, where the subject's study participation could present an undue safety risk or obscure the evaluation of study endpoints, per Investigator/Examiner discretion
  • Oral surgery within the last 2 months Currently using professionally dispensed bleaching products
  • A known allergy or sensitivity to products planned for use in this study
  • Unwilling to abstain from all other oral hygiene products other than those prescribed for the duration of the study
  • Participated in an oral care study within the previous 60 days
  • Employee or a relative of an employee of the Site clinical research department, dental school, or a dental products manufacturing, research or marketing firm
  • Dental student or dental professional
  • A cardiac pacemaker or implanted cardiac defibrillator
  • Insulin-Dependent Diabetes
  • Current use of antibiotic medications or use within 4 weeks of enrollment
  • Current use of prescription-dose anti-inflammatory medications or anticoagulants; (including aspirin > 81 mg daily)
  • Presence of advanced periodontal disease or excessive gingival recession, per Investigator/Examiner discretion
  • Heavy deposits of calculus, either supragingival and/or subgingival, per Investigator/Examiner discretion
  • Extensive crown or bridge work and/or rampant decay, per Investigator/Examiner discretion
  • Presence of orthodontic bands, wires or brackets
  • A professional prophylaxis within 4 weeks of the study
  • Regular power toothbrush user

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Manual Toothbrush
Administered using Colgate Classic Adult Manual Toothbrush
Enhed: manual toothbrush
Colgate Classic Adult manual toothbrush
Eksperimentel: Power Toothbrush
Administered using Sonicare Power toothbrush with All-in-One brush head
Enhed: power toothbrush
Sonicare Powered Toothbrush and All-in-One Brush head

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Compare the reduction in surface plaque for power toothbrush to manual toothbrush after 6 weeks
Tidsramme: 6 weeks

Surface plaque measured by Lobene and Soparkar Modified Quigley-Hein Plaque Index (MPI) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=no plaque,

  1. separate flecks of plaque at the cervical margin of the tooth,
  2. a thin continuous band of plaque (up to 1 mm) at the cervical margin of the tooth,
  3. a band of plaque wider than 1 mm covering less than one third of the crown of the tooth,
  4. plaque covering at least one-third but less than two-thirds of the crown of the tooth,
  5. plaque covering two-thirds or more of the crown of the tooth.

Change in MPI will be calculated by subtracting follow-up MPI score from baseline MPI score. Differences in MPI will be compared between the manual and power toothbrush groups.
6 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Compare the reduction in surface plaque for power toothbrush to manual toothbrush after 2 weeks
Tidsramme: 2 weeks

Surface plaque measured by Lobene and Soparkar Modified Quigley-Hein Plaque Index (MPI) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=no plaque,

  1. separate flecks of plaque at the cervical margin of the tooth,
  2. a thin continuous band of plaque (up to 1 mm) at the cervical margin of the tooth,
  3. a band of plaque wider than 1 mm covering less than one third of the crown of the tooth,
  4. plaque covering at least one-third but less than two-thirds of the crown of the tooth,
  5. plaque covering two-thirds or more of the crown of the tooth.

Change in MPI will be calculated by subtracting follow-up MPI score from baseline MPI score. Differences in MPI will be compared between the manual and power toothbrush groups.
2 weeks
Compare the reduction in gingivitis for power toothbrush to manual toothbrush after 2 weeks
Tidsramme: 2 weeks

Gingivitis is measured by Modified Gingival Index (MGI) (Lobene et al 1986) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=absence of inflammation,

  1. mild inflammation; slight change in color, little change in texture of the marginal or papillary gingival unit,
  2. mild inflammation; criteria as shown above but involving the entire marginal or papillary gingiva,
  3. moderate inflammation glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingiva,
  4. severe inflammation, marked redness, edema, and/or hypertrophy of the marginal or papillary gingiva, spontaneous bleeding, congestion or ulceration.

Change in MGI will be calculated by subtracting follow-up MPI score from baseline MGI score. Differences in MGI will be compared between the manual and power toothbrush groups.
2 weeks
Compare the reduction in gingivitis for power toothbrush to manual toothbrush after 6 weeks
Tidsramme: 6 weeks

Gingivitis is measured by Modified Gingival Index (MGI) (Lobene et al 1986) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0=absence of inflammation,

  1. mild inflammation; slight change in color, little change in texture of the marginal or papillary gingival unit,
  2. mild inflammation; criteria as shown above but involving the entire marginal or papillary gingiva,
  3. moderate inflammation glazing, redness, edema, and/or hypertrophy of the marginal or papillary gingiva,
  4. severe inflammation, marked redness, edema, and/or hypertrophy of the marginal or papillary gingiva, spontaneous bleeding, congestion or ulceration.

Change in MGI will be calculated by subtracting follow-up MPI score from baseline MGI score. Differences in MGI will be compared between the manual and power toothbrush groups.
6 weeks
Compare the reduction in gingival bleeding for power toothbrush to manual toothbrush after 2 weeks
Tidsramme: 2 weeks

Gingival bleeding is measured by Gingival Bleeding Index (GBI), (Van der Weijden et al 1994) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0 = no bleeding,

  1. = bleeding on gently probing,
  2. = bleeding appears immediately upon gently probing,
  3. = spontaneous bleeding which is present prior to probing.

Change in GBI will be calculated by subtracting follow-up GBI score from baseline GBI score. Differences in GBI will be compared between the manual and power toothbrush groups.
2 weeks
Compare the reduction in gingival bleeding for power toothbrush to manual toothbrush after 6 weeks
Tidsramme: 6 weeks

Gingival bleeding is measured by Gingival Bleeding Index (GBI), (Van der Weijden et al 1994) using six sites per tooth (distobuccal, buccal, mesiobuccal and distolingual, lingual, mesiolingual) where 0 = no bleeding,

  1. = bleeding on gently probing,
  2. = bleeding appears immediately upon gently probing,
  3. = spontaneous bleeding which is present prior to probing.

Change in GBI will be calculated by subtracting follow-up GBI score from baseline GBI score. Differences in GBI will be compared between the manual and power toothbrush groups.
6 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Philips Clinical & Medical Affairs Global

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

5. oktober 2020

Primær færdiggørelse (Faktiske)

20. november 2020

Studieafslutning (Faktiske)

20. november 2020

Datoer for studieregistrering

Først indsendt

5. juni 2026

Først indsendt, der opfyldte QC-kriterier

7. juli 2026

Først opslået (Faktiske)

9. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

7. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • OHC_OHC_Xi'an_2020_10863

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Data is available upon request

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner